News Medial EarlySign's AI scans medical records for kidney disea... A machine learning technology developed to spot dangerous medical conditions before they worsen has shown its value in a trial.
Views & Analysis Pharma R&D is crying out for disruption – is AI the answer? Artificial Intelligence (AI), big data and genomics are coming together to revolutionise drug discovery and development.
News Nearly half of life science professionals using AI - survey But lack of technical expertise holding back projects.
Events Partner Content Blockchain for Clinical Trials Forum Setting a New Standard for Optimizing Clinical Trials
News Budget 2017: Artificial Intelligence funds welcome, but bold... UK AI leader welcomes increased investment but suggests more needs to be done.
News Google's new accelerator aims to foster AI startups Augmedix, BrainQ, ByteFlies and Cytovale make up first accelerator cohort.
News Court sides with EU on decision to revoke Ocaliva's license Advanz Pharma's bid to keep its Ocaliva treatment for rare liver disease primary biliary cholangitis (PBC) on the EU market has ended in failure
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends